Sign In
Buy STXS
$1.84
-0.130 (-6.60%)
At Close: Jun 03, 2026
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
07:32am, Wednesday, 15'th Oct 2025
ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation
01:55pm, Tuesday, 14'th Oct 2025
Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
07:34am, Monday, 13'th Oct 2025
ST. LOUIS and MARLBOROUGH, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and Car
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
02:16pm, Tuesday, 23'rd Sep 2025
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System
07:56am, Monday, 22'nd Sep 2025
ST. LOUIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced successful fi
STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep
09:51am, Wednesday, 03'rd Sep 2025
Stereotaxis debuts MAGiC Sweep, the first U.S. robotic HD mapping catheter, marking a breakthrough in cardiac arrhythmia diagnosis and treatment.
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter
08:08am, Tuesday, 02'nd Sep 2025
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the successfu
Stereotaxis to Present at Upcoming Investor Conferences
07:51am, Tuesday, 02'nd Sep 2025
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fi
Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025
07:47am, Thursday, 28'th Aug 2025
ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology
Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript
01:24pm, Friday, 08'th Aug 2025
Stereotaxis, Inc. (NYSE:STXS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants David Leo Fischel - CEO & Chairman Kimberly R. Peery - Chief Financial Officer Conference
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates
06:40pm, Thursday, 07'th Aug 2025
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago.
Stereotaxis Reports 2025 Second Quarter Financial Results
04:01pm, Thursday, 07'th Aug 2025
ST. LOUIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial resul
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know
11:07am, Thursday, 31'st Jul 2025
Stereotaxis (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
07:48am, Monday, 28'th Jul 2025
ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has re
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
08:00am, Wednesday, 23'rd Jul 2025
ST. LOUIS, July 23, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will r
